Codes / ICD10CM / T42.6X3S

T42.6X3S Poisoning by other antiepileptic and sedative-hypnotic drugs, assault, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

Poisoning by other antiepileptic and sedative-hypnotic drugs, assault, sequela
ICD-10 Code: T42.6X3S

Summary

This code applies to the sequela (late effects) of poisoning by antiepileptic and sedative-hypnotic drugs resulting from assault. It covers clinical scenarios where residual or chronic effects persist after the initial poisoning event, focusing on the assaultive nature of the exposure and the specific drug class involved.

Causes

Sequela in this context result from prior poisoning by antiepileptic or sedative-hypnotic drugs administered intentionally by another party without consent. The initial event may involve forced ingestion, injection, or other means of exposure, with lasting effects emerging after the acute phase.

Risk Factors

  • History of assault-related poisoning by these drug classes.
  • Inadequate follow-up or rehabilitation after the initial event.
  • Pre-existing conditions affecting recovery (e.g., neurological or respiratory impairment).
  • Lack of ongoing medical monitoring for long-term complications.

Symptoms

  • Persistent neurological deficits (e.g., cognitive impairment, memory loss).
  • Chronic respiratory issues (e.g., reduced lung function, recurrent infections).
  • Ongoing psychiatric symptoms (e.g., anxiety, depression, PTSD).
  • Physical disabilities from prolonged sedation or seizures.
  • Gastrointestinal or metabolic complications from drug toxicity.

Diagnosis

Diagnosis requires clinical evaluation of residual symptoms, confirmation of prior assault-related poisoning, and exclusion of other causes. Documentation should link current findings to the initial event, with imaging or lab tests supporting long-term effects.

Treatment Options

Management focuses on addressing chronic symptoms and improving quality of life. This may include rehabilitation therapies (physical, occupational, or cognitive), psychiatric support, and ongoing monitoring for organ system damage. Symptomatic treatments target specific residual effects (e.g., respiratory aids, seizure management).

Prognosis and Follow-Up

Prognosis depends on the severity of initial poisoning and residual damage. Regular follow-up is essential to monitor for worsening symptoms or new complications. Long-term care may involve multidisciplinary teams to address physical, cognitive, and emotional needs.

Complications

  • Permanent neurological damage (e.g., cognitive decline, motor deficits).
  • Chronic respiratory failure or dependence on ventilation.
  • Persistent psychiatric disorders (e.g., PTSD, depression).
  • Organ damage (e.g., liver or kidney impairment from drug toxicity).
  • Reduced functional independence requiring ongoing support.

Lifestyle & Prevention

  • Adherence to prescribed rehabilitation and therapy plans.
  • Avoidance of triggers or environments associated with the initial assault.
  • Use of assistive devices or modifications to support daily activities.
  • Psychological counseling to address trauma-related effects.
  • Regular medical check-ups to detect and manage complications early.

When to Seek Professional Help

Seek immediate care for new or worsening symptoms (e.g., severe confusion, difficulty breathing, seizures). Contact a healthcare provider for persistent pain, mood changes, or signs of organ dysfunction. Emergency services are warranted for life-threatening issues.

Tips for Medical Coders

Document the sequela clearly, linking them to the prior assault-related poisoning. Include details on the nature of residual effects and their impact on daily functioning. Ensure the code T42.6X3S is used only when the sequela are directly attributable to the initial event.

Book a walkthrough

T42.6X3S policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.